" /> Brilacidin - CISMeF





Preferred Label : Brilacidin;

NCIt definition : A synthetic, nonpeptidic, small molecule mimetic of defensin, a type of host defense proteins/peptides (HDPs) or antimicrobial peptides (AMPs), with potential antibacterial and antiviral activities. Upon administration, brilacidin selectively destabilizes bacterial and viral membrane integrity, which leads to their proteolysis and degradation. HDPs are part of the innate immune response and act as the first line of defense against foreign pathogens. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has been shown to suppress defensins.;

UNII : I1679X069H;

InChIKey : QPDYBCZNGUJZDK-DNQXCXABSA-N;

CAS number : 1224095-98-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1224095-98-0 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : PMX-30063; PMX 30063;

NCI Metathesaurus CUI : CL1382168;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
21/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.